Display options
Share it on

Int J Clin Exp Pathol. 2013;6(4):546-60. Epub 2013 Mar 15.

Invasion of primary glioma- and cell line-derived spheroids implanted into corticostriatal slice cultures.

International journal of clinical and experimental pathology

Charlotte Aaberg-Jessen, Annette Nørregaard, Karina Christensen, Christian B Pedersen, Claus Andersen, Bjarne W Kristensen

Affiliations

  1. Department of Pathology, Odense University Hospital, Odense, Denmark.

PMID: 23573302 PMCID: PMC3606845

Abstract

Gliomas are highly invasive tumors and the pronounced invasive features of gliomas prevent radical surgical resection. In the search for new therapeutics targeting invasive glioma cells, in vivo-like in vitro models are of great interest. We developed and evaluated an in vivo-like in vitro model preserving the invasive features and stem cell features of glioma cells. Fluorescently labelled primary glioma spheroids and U87MG cell line-derived spheroids were implanted into organotypic rat corticostriatal slice cultures and the invasion was followed over time by confocal microscopy. The invasion was validated immunohistochemically with paraffin sections using a human-specific vimentin antibody. Moreover, the preservation of immature stem cell features was evaluated immunohistochemically using the stem cell markers CD133, Sox2, Bmi-1 and nestin. The confocal and immunohistochemical results showed that the primary glioma spheroid area was constant or decreasing after implantation, with a clear increase in the number of invading cells over time. In contrast, the U87MG spheroid area increased after implantation, with no convincing tumor cell invasion. High levels of Bmi-1 and nestin were found in all spheroids, whereas high levels of Sox2 and low to moderate levels of CD133 were only found in the primary spheroids. In conclusion, the invasion of gliomas is preserved using primary glioma spheroids. Some stem cell features are preserved as well, making this model useful in drug development elucidating both invasion and cancer stemness at the early in vitro level.

Keywords: Glioma; invasion; organotypic slice cultures; spheroids

References

  1. Eur J Cancer. 1997 Apr;33(4):645-51 - PubMed
  2. Cancer Cell. 2006 Dec;10(6):454-6 - PubMed
  3. BMC Neurosci. 2008 Jan 30;9:15 - PubMed
  4. Cancer Res. 2003 Sep 15;63(18):5821-8 - PubMed
  5. J Neurosurg. 1990 Mar;72(3):463-75 - PubMed
  6. Bull Cancer. 2012 Dec;99(12):1153-60 - PubMed
  7. Oncol Rep. 2006 Jan;15(1):97-105 - PubMed
  8. J Histochem Cytochem. 2005 Jan;53(1):23-34 - PubMed
  9. Mol Cancer. 2006 Dec 02;5:67 - PubMed
  10. Cancer Res. 2004 Oct 1;64(19):7011-21 - PubMed
  11. Brain Res Brain Res Protoc. 2004 Aug;13(3):135-43 - PubMed
  12. J Neurosurg. 2001 Jan;94(1):80-9 - PubMed
  13. J Neurooncol. 2011 Aug;104(1):129-43 - PubMed
  14. Nature. 2006 Dec 7;444(7120):756-60 - PubMed
  15. Surg Neurol. 2007 Aug;68(2):133-43; discussion 143-4 - PubMed
  16. Cancer Cell. 2006 May;9(5):391-403 - PubMed
  17. Biochem Biophys Res Commun. 2000 Mar 16;269(2):513-20 - PubMed
  18. J Neurosurg. 2002 Jul;97(1):169-76 - PubMed
  19. Brain Res. 2009 Oct 6;1292:107-22 - PubMed
  20. Int J Cancer. 1996 Jul 17;67(2):275-82 - PubMed
  21. Proc Natl Acad Sci U S A. 2011 Mar 1;108(9):3749-54 - PubMed
  22. Clin Cancer Res. 2008 Jan 1;14(1):123-9 - PubMed
  23. Br J Cancer. 2007 Apr 23;96(8):1293-301 - PubMed
  24. J Neurooncol. 1998 May;38(1):1-10 - PubMed
  25. J Clin Oncol. 2008 Jun 20;26(18):3015-24 - PubMed
  26. Acta Pathol Microbiol Scand. 1968;74(4):465-86 - PubMed
  27. J Clin Invest. 2005 Jun;115(6):1503-21 - PubMed
  28. Nature. 2004 Nov 18;432(7015):396-401 - PubMed
  29. Lancet Oncol. 2009 May;10(5):459-66 - PubMed
  30. J Neurosci Methods. 1991 Apr;37(2):173-82 - PubMed
  31. J Neurosurg. 1999 Jan;90(1):125-32 - PubMed
  32. Anticancer Res. 2003 Mar-Apr;23(2B):1461-6 - PubMed
  33. Neuropathol Appl Neurobiol. 1995 Oct;21(5):386-91 - PubMed
  34. Cancer Lett. 2008 Jun 28;265(1):124-34 - PubMed
  35. Oncol Rep. 2004 Feb;11(2):477-85 - PubMed
  36. Br J Cancer. 2001 May 18;84(10):1372-6 - PubMed
  37. Oncogene. 2004 Sep 20;23(43):7267-73 - PubMed
  38. J Cancer Res Clin Oncol. 2005 Nov;131(11):723-32 - PubMed
  39. Cancer Res. 2006 Aug 15;66(16):7843-8 - PubMed
  40. Br J Cancer. 2004 Aug 16;91(4):745-52 - PubMed
  41. Brain Res Brain Res Protoc. 1999 Jan;3(3):278-90 - PubMed
  42. Stem Cells Dev. 2007 Oct;16(5):837-47 - PubMed
  43. J Cancer Res Clin Oncol. 2002 Sep;128(9):469-76 - PubMed
  44. Brain Res. 1999 Sep 11;841(1-2):143-59 - PubMed
  45. Cell. 1999 Jan 8;96(1):25-34 - PubMed
  46. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15178-83 - PubMed
  47. Neurosurgery. 2010 May;66(5):933-47 - PubMed
  48. J Neurooncol. 2008 Nov;90(2):157-70 - PubMed
  49. Anticancer Res. 1990 Sep-Oct;10(5A):1135-51 - PubMed
  50. Cancer Biol Ther. 2007 Jul;6(7):1018-24 - PubMed

Substances

MeSH terms

Publication Types